Literature DB >> 20015735

Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypopharynx.

Pen-Yuan Chu1, Shyue-Yih Chang, Jui-Lin Huang, Shyh-Kuan Tai.   

Abstract

PURPOSE: The aim of the present study was to compare the incidence, patterns, and survival of second primary malignancy (SPM) in patients with squamous cell carcinoma of the larynx (LSCC) and hypopharynx (HPSCC).
METHODS: We retrospectively review the medical record of 581 previously untreated patients with LSCC (392 cases) and HPSCC (189 cases) who received primary surgery with or without postoperative radiotherapy from 1990 to 2000. Data including age, sex, risk factors, subsites and TNM stage of primary tumor, treatment, site and incidence of SPM, and prognosis were collected from medical charts.
RESULTS: Groups with HPSCC had a higher incidence (4.2% vs 2.9% annual rate) and shorter median time (30 vs 59 months) developing SPM rather than LSCC. Fifty-five percent of the SPM occurred in the respiratory axis in LSCC, and 66% developed in the digestive axis in HPSCC. The factors influencing the appearance of SPM included early T stage, tobacco use, and less tumor recurrence. Long-term survival was poorer in those with than without SPM (38% vs 49% at 10 years).
CONCLUSIONS: There is a tendency for SPM to occur in the respiratory axis (lung and larynx) in LSCC and in the digestive axis (oral cavity, pharynx, and esophagus) in HPSCC. This information is important for posttreatment follow-up. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20015735     DOI: 10.1016/j.amjoto.2008.12.004

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  5 in total

Review 1.  Causes of death of patients with laryngeal cancer.

Authors:  Alfio Ferlito; Missak Haigentz; Patrick J Bradley; Carlos Suárez; Primož Strojan; Gregory T Wolf; Kerry D Olsen; William M Mendenhall; Vanni Mondin; Juan P Rodrigo; Carsten C Boedeker; Marc Hamoir; Dana M Hartl; Jennifer L Hunt; Kenneth O Devaney; Lester D R Thompson; Alessandra Rinaldo; Robert P Takes
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-17       Impact factor: 2.503

2.  Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients.

Authors:  Yasuhiko Hamada; Toshiro Mizuno; Kyosuke Tanaka; Masaki Katsurahara; Noriyuki Horiki; Reiko Yamada; Hiroyuki Inoue; Yoshiyuki Takei; Naoyuki Katayama
Journal:  Int J Clin Oncol       Date:  2017-10-24       Impact factor: 3.402

3.  Treatment Modality and Second Primary Tumors of the Head and Neck.

Authors:  Gal Ben Arie; Tali Shafat; Olga Belochitski; Sabri El-Saied; Ben-Zion Joshua
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2021-09-29       Impact factor: 1.538

4.  Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient?

Authors:  Mohammad Adeel; Moghira Iqbal Siddiqi
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2018-10-26

5.  Dynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis.

Authors:  Chung-Ji Liu; Wan-Jung Chang; Chang-Yi Chen; Fang-Ju Sun; Hui-Wen Cheng; Tsai-Ying Chen; Shu-Chun Lin; Wan-Chun Li
Journal:  Oncotarget       Date:  2015-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.